Review article: a medicine based on cell transplantation - is there a future for treating liver diseases?

被引：13

作者：

Di Campli, C ^{[1
]}

Gasbarrini, G ^{[1
]}

Gasbarrini, A ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2003年 / 18卷 / 05期

关键词：

D O I：

10.1046/j.1365-2036.2003.01692.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Cell-based therapies, comprising isolated hepatocyte transplantation, ex vivo gene therapy and bioartificial liver devices, may actually design a new scenario in the treatment of patients with liver failure. Recent advances in the liver repopulation field and the considerable excitement surrounding the use of haematopoietic stem cells for a 'regenerative medicine', allow us to see under a new light the alternative cell sources actually under investigation. In particular, the major drawbacks and the most important advantages of xenogenic primary cells, tumour-derived cell lines, immortalised hepatocytes and stem cells in the wide range of experimental and clinical applications are presented. Even if up to now none of them represent a 'gold standard' in the clinical practice, the intersecting advances in the development of mechanical components of artificial devices and in the liver biology and bioengineering will open tantalising possibilities to treat patients with liver failure, by tailoring the therapeutic choice on the basis of the aetiology and the stage of liver disease.

引用

页码：473 / 480

页数：8

共 58 条

[1] Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis
Akashi, K
He, X
Chen, J
Iwasaki, H
Niu, C
Steenhard, B
Zhang, JW
Haug, J
Li, LH
[J]. BLOOD, 2003, 101 (02) : 383 - 390
[2] Advances in bioartificial liver devices
Allen, JW
Hassanein, T
Bhatia, SN
[J]. HEPATOLOGY, 2001, 34 (03) : 447 - 455
[3] Hepatic regeneration from hematopoietic stem cells
Austin, TW
Lagasse, E
[J]. MECHANISMS OF DEVELOPMENT, 2003, 120 (01) : 131 - 135
[4] Auth M K, 1998, Transpl Int, V11 Suppl 1, pS439, DOI 10.1111/j.1432-2277.1998.tb01176.x
[5] Ballen KK, 2000, SEMIN ONCOL, V27, P512
[6] Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver
Baquerizo, A
Mhoyan, A
Shirwan, H
Swensson, J
Busuttil, RW
Demetriou, AA
Cramer, DV
[J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 964 - 965
[7] Coleman WB, 1997, AM J PATHOL, V151, P353
[8] Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver
Dabeva, MD
Hwang, SG
Vasa, SRG
Hurston, E
Novikoff, PM
Hixson, DC
Gupta, S
Shafritz, DA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7356 - 7361
[9] C1qRp defines a new human stem cell population with hernatopoietic and hepatic potential
Danet, GH
Luongo, JL
Butler, G
Lu, MM
Tenner, AJ
Simon, MC
Bonnet, DA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10441 - 10445
[10] Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation
de Haan, A
van den Berg, AP
van der Bij, W
Hepkema, BG
Bruin-van Dijk, E
van der Gun, I
Lems, SPM
Slooff, MJH
Haagsma, EB
de Leij, LFMH
Prop, J
[J]. TRANSPLANTATION, 2001, 71 (06) : 785 - 791

← 1 2 3 4 5 6 →